Principaux concurrents
Rendement du dividende (N) Rendement du dividende (N+1) PER (N) Price to Book (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Capi.($)
- - - - - - - 558 M
0,59%0,68%17.24x1.95x3.69x9.5x11.02x 66,32 Md
0,6%0,62%26.03x3.94x5.39x15.83x19.62x 52,6 Md
-.--%-.--%33.71x6.94x11.47x21.71x25.74x 43,27 Md
3,53%3,62%-42.82x2.4x3.08x9.11x10.63x 38,64 Md
-.--%-.--%24.39x1.59x3.47x11.8x13.68x 29,62 Md
-.--%-.--%56.3x4.18x3.29x27.65x28.03x 23,31 Md
-.--%-.--%-6.59x3.99x9.17x-5.65x-5.29x 22,62 Md
-.--%0,05%65.79x5.91x6.47x44.55x50.25x 20,22 Md
-.--%-.--%24.1x3.53x5.16x13.51x18.67x 16,29 Md
-.--%-.--%-37.28x-6.61x17.78x-48.68x-56.26x 16,26 Md
-.--%-.--%-117.16x12792.9x12.58x-90.09x-125.57x 12,43 Md
-.--%-.--%17.43x - 3.59x13.87x16.19x 11,38 Md
-.--%-.--%43.85x - - - - 9,65 Md
0,17%0,17%56.08x22.87x33.96x48.03x49.53x 11,13 Md
2,76%3,15%12.47x1.11x1.83x7.37x9.96x 6,46 Md
Moyenne 0,51% 0,55% 11,57x 988,05x 8,64x 5,61x 4,73x 23,8 Md
Moyenne pondérée par Capi. 0,6% 0,63% 13,65x 446,30x 7,07x 9,63x 10,45x
Biopharmacies